Aspira Women's Health Inc. (AWH)
NASDAQ: AWH · IEX Real-Time Price · USD
3.327
+0.047 (1.42%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Aspira Women's Health Revenue
In the year 2023, Aspira Women's Health had annual revenue of $9.15M with 11.85% growth. Revenue in the quarter ending December 31, 2023 was $2.13M, a -1.07% decrease year-over-year.
Revenue (ttm)
$9.15M
Revenue Growth
+11.85%
P/S Ratio
4.49
Revenue / Employee
$143,031
Employees
64
Market Cap
41.06M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.15M | 970.00K | 11.85% |
Dec 31, 2022 | 8.18M | 1.37M | 20.14% |
Dec 31, 2021 | 6.81M | 2.16M | 46.46% |
Dec 31, 2020 | 4.65M | 113.00K | 2.49% |
Dec 31, 2019 | 4.54M | 1.49M | 48.64% |
Dec 31, 2018 | 3.05M | -68.00K | -2.18% |
Dec 31, 2017 | 3.12M | 479.00K | 18.13% |
Dec 31, 2016 | 2.64M | 465.00K | 21.36% |
Dec 31, 2015 | 2.18M | -344.00K | -13.65% |
Dec 31, 2014 | 2.52M | -45.00K | -1.75% |
Dec 31, 2013 | 2.57M | 472.00K | 22.54% |
Dec 31, 2012 | 2.09M | 171.00K | 8.89% |
Dec 31, 2011 | 1.92M | 748.00K | 63.66% |
Dec 31, 2010 | 1.18M | - | - |
Dec 31, 2009 | 0 | - | - |
Dec 31, 2008 | 124.00K | 80.00K | 181.82% |
Dec 31, 2007 | 44.00K | -18.17M | -99.76% |
Dec 31, 2006 | 18.22M | -9.03M | -33.15% |
Dec 31, 2005 | 27.25M | -12.94M | -32.19% |
Dec 31, 2004 | 40.18M | -3.46M | -7.92% |
Dec 31, 2003 | 43.64M | 14.43M | 49.40% |
Dec 31, 2002 | 29.21M | 10.16M | 53.33% |
Dec 31, 2001 | 19.05M | 10.11M | 113.20% |
Dec 31, 2000 | 8.94M | 3.93M | 78.34% |
Dec 31, 1999 | 5.01M | 2.08M | 70.81% |
Dec 31, 1998 | 2.93M | 648.00K | 28.36% |
Dec 31, 1997 | 2.29M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Oncology Network | 1.28B |
Cutera | 230.18M |
Rockwell Medical | 83.61M |
Rapid Micro Biosystems | 22.52M |
ReWalk Robotics | 13.85M |
Milestone Scientific | 9.83M |
Bolt Biotherapeutics | 7.88M |
Renalytix | 2.41M |
AWH News
- 18 days ago - Aspira Women's Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California - GlobeNewsWire
- 4 weeks ago - Aspira Women's Health Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 5 weeks ago - Aspira Women's Health to Present at the MedInvest Biotech & Pharma Investor Conference - GlobeNewsWire
- 6 weeks ago - Aspira Women's Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024 - GlobeNewsWire
- 2 months ago - Aspira Women's Health to Present at The Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference - GlobeNewsWire
- 2 months ago - Aspira Women's Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI) - GlobeNewsWire
- 4 months ago - Aspira Women's Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024 - GlobeNewsWire
- 4 months ago - Aspira Women's Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024 - GlobeNewsWire